\
&
Contact us
\
&
Contact us
Published on | 1 year ago
Programmes Digital, Industry & Space AI ContinentThe Commission is collecting feedback on the rules to set up a new scientific advisory group of independent experts on artificial intelligence.
The AI Act foresees a scientific panel of independent experts on AI to assist the AI Office and national authorities in the implementation and enforcement of the AI Act. This advisory body will play a key role in the governance, offer technical advice and input on enforcement, including the ability to alert the AI Office of risks posed by a general-purpose AI model.
The Commission will adopt an implementing act to lay down the rules and procedures for establishing and operating this scientific panel. Once these rules are in place, the Commission will launch a call for expression of interest to select the experts.
The draft implementing act is open for public feedback via the Have Your Say portal. You can Submit your comments by 15 November 2024.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
